#ScreenB4Vaccine And Labcorp of America: The Perfect Partners in Defense of US Public Health Against COVID-19 Harm.

Hooman Noorchashm
4 min readApr 6, 2021

--

Labcorp of America, led by CEO Adam Schechter, and #ScreenB4Vaccine are natural partners for establishment of an unprecedented public health and safety device in the the vaccine space. Labcorp and #ScreenB4Vaccine, together, will materialize a new era of safe and personalized vaccine prophylaxis.

Millions of Americans are already naturally infected with the COVID-19 virus.

It is my opinion as a physician, immunologist and public health advocate that indiscriminate vaccination of such recently or previously infected persons is unnecessary or potentially dangerous.

I’ve previously written extensively about the potential problem with, and likely danger of, vaccinating the already infected.

An interview with Tucker Carlson about the importance of careful vaccine safety considerations and #ScreenB4Vaccine, etc.

I recently had an extensive conversation with Tucker Carlson at FOX about my safety concerns and the potential danger of indiscriminately vaccinating persons recently infected with COVID-19. I do find it puzzling that Mr. Carlson and FOX are the only media outlets interested in considering safety concerns about the COVID-19 vaccine.

You may read my opinions about indiscriminate vaccination of the already infected HERE, HERE, HERE and HERE.

Given the potential safety risk of indiscriminately vaccinating persons with recent known or occult COVID-19 infections, I’ve introduced the idea of #ScreenB4Vaccine to our public health officials at FDA and CDC — as well as to the COVID-19 vaccine manufacturers.

But the “experts”, neither at FDA nor at the vaccine manufacturing companies, seem to accept the clear immunological prognostication that indiscriminate vaccination of the recently infected may be a public safety hazard — they, in fact, have state that there is “no evidence” for such a danger and that it may even be unfounded to suggest that there is potential danger. Even though, they all recognize the significant limitations of the clinical trial design leading to the EUA for the COVID-19 vaccines. In fact, entire subsets of people were very literally missing from or were vastly under-represented in these trials: including the recently COVID-19 infected, of all stripes.

So, in the unfortunate, but not unexpected, absence of sufficient vigilance and care on the part of FDA, CDC and the vaccine manufacturers, I have brought the concept #ScreenB4Vaccine to all concerned American citizens.

In truth, every one of us in America during this pandemic has the ability and right to use #ScreenB4Vaccine as an information and safety “device” to assess the status of our immunity to SARS-CoV-2. Certainly at the moment, every American also has the right to exercise choice over making an informed decision as to whether to get vaccinated based on the status of his or her immunity. One can only hope that reason can prevail in America and that Americans remain free thinkers and actors, with risk informed choices over their own bodies and decisions to protect our nation as individuals.

For the public record, it is my professional opinion that any persons without immunity are susceptible to the infectious, morbidity and mortality risks of the SARS-CoV-2 pandemic virus and, therefore, ought to consider immediate COVID-19 vaccination — not only to protect themselves but also to protect the nation.

Here, I write to inform the public that in exercising safe and prudent choice over whether or not to get vaccinated, we the citizens of the United States of America, have a powerful partner: Laboratory Corporation of America, also known as Labcorp, led by CEO, Mr. Adam Schechter.

Every American today knows that, literally, every corner of America is populated by a well equipped and convenient Labcorp outpatient facility capable of drawing the blood samples necessary to execute #ScreenB4Vaccine for any Americans who might wish to make a truly informed vaccine decision based on the status of their immunity against SARS-CoV-2.

I believe that a partnership between Labcorp of America and #ScreenB4Vaccine, driven by everyday Americans demanding cogent vaccination, will not only become an historic patient safety contribution from the private sector — but, more importantly, it will also result in a revolutionary personalization of vaccination prophylaxis towards maximal patient safety in clinical care.

The American people, during this pandemic, have a choice: Accept “1-size-fits-all” but potentially dangerous indiscriminate vaccination in the midst of a pandemic outbreak — OR — rational, safe and efficient vaccination using #ScreenB4Vaccine at their local Labcorp outpatient facility.

The beauty of America has always been the rationality and power of the American consumer in shaping our government’s, professions’ and corporations’ policies, practices and ethical conduct as it pertains to public health and safety.

Today, April 5, 2021, indiscriminate COVID-19 vaccination of the recently infected is highly likely to be hazard to the public — but THE PUBLIC and its demand for maximal safety mitigation is the only force that can practically marry #ScreenB4Vaccine and Labcorp in order to defend itself against this potential risk of avoidable harm.

#ScreenB4Vaccine + Labcorp = Public safety in the vaccine space.

In friendship to all citizens and in defense of US public health,

Hooman Noorchashm MD, PhD.

noorchashm@gmail.com

--

--

Hooman Noorchashm
Hooman Noorchashm

Written by Hooman Noorchashm

Hooman Noorchashm MD, PhD is a physician-scientist. He is an advocate for ethics, patient safety and women’s health. He and his 6 children live in Pennsylvania.

No responses yet